<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>The Effects of Federal Indirect Cost Recovery on Academic Institutions</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>07/15/2017</AwardEffectiveDate>
<AwardExpirationDate>12/31/2019</AwardExpirationDate>
<AwardTotalIntnAmount>427892.00</AwardTotalIntnAmount>
<AwardAmount>427892</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>04010000</Code>
<Directorate>
<Abbreviation>SBE</Abbreviation>
<LongName>Direct For Social, Behav &amp; Economic Scie</LongName>
</Directorate>
<Division>
<Abbreviation>SMA</Abbreviation>
<LongName>SBE Off Of Multidisciplinary Activities</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Cassidy Sugimoto</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>About one-third of the of the approximately $30 billion spent annually by U.S. taxpayers on biomedical research  is used for indirect cost payments to universities and other grant recipients. These overhead costs are meant to help support infrastructure, utilities, and administration. Institutional indirect cost recovery rates are determined through notoriously complex negotiations between grantees and funding agencies and have been the source of significant controversy in science policy for decades. One view is that these rates are too high. This view came into focus during the so-called Stanford scandal in the 1990s, when some private universities were accused of enlarging their indirect cost recovery rates through improper accounting procedures. There are long-standing complaints by scientists that higher indirect cost rates mean less funding for actual research, and  that indirect cost policy creates incentives for universities to over-invest in research capacity, including new building, and hiring of soft money faculty. On the other hand, universities have long argued that indirect costs rates under-compensate universities, and that in effect universities lose money on many grants. Getting the rate and incentive right is important and will help ensure that limited biomedical research funds are used most efficiently and effectively towards advancing knowledge and health. &lt;br/&gt;&lt;br/&gt;There is little empirical evidence to guide the ongoing debate. This project provides new data on indirect cost rates and estimates the impact on academic research. A new open-source dataset on indirect cost rates will be provided along with a statistical overview of how and why rates differ by institution and over time, and how variation influences total funding available for research. The dataset is accompanied by code to allow researchers, journalists, government officials, and other stakeholders to explore the data independently and link to other sources. using these data, the project examines how changes in indirect cost rates affect institutional incentives to seek grants, to grow faculty, build, and make other investments. One challenge is to separate the effects of indirect cost rates from other potentially confounding factors. To ameliorate this, the research exploits various natural experiments in indirect cost policy, providing more confidence in the estimates. Finally, the project also considers the effects of historical changes in indirect cost recovery policy influenced the expansion and productivity of the biomedical research enterprise, and whether it reinforced disparities across research performers.</AbstractNarration>
<MinAmdLetterDate>07/05/2017</MinAmdLetterDate>
<MaxAmdLetterDate>07/05/2017</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.075</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>1735413</AwardID>
<Investigator>
<FirstName>Pierre</FirstName>
<LastName>Azoulay</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Pierre Azoulay</PI_FULL_NAME>
<EmailAddress>pazoulay@mit.edu</EmailAddress>
<PI_PHON>6172589766</PI_PHON>
<NSF_ID>000075890</NSF_ID>
<StartDate>07/05/2017</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Bhaven</FirstName>
<LastName>Sampat</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Bhaven Sampat</PI_FULL_NAME>
<EmailAddress>bns3@columbia.edu</EmailAddress>
<PI_PHON>2128546851</PI_PHON>
<NSF_ID>000555390</NSF_ID>
<StartDate>07/05/2017</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Columbia University</Name>
<CityName>NEW YORK</CityName>
<ZipCode>100276902</ZipCode>
<PhoneNumber>2128546851</PhoneNumber>
<StreetAddress>2960 Broadway</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>New York</StateName>
<StateCode>NY</StateCode>
<CONGRESSDISTRICT>10</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>NY10</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>049179401</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM>049179401</ORG_PRNT_DUNS_NUM>
</Institution>
<Performance_Institution>
<Name><![CDATA[Columbia University]]></Name>
<CityName>New York</CityName>
<StateCode>NY</StateCode>
<ZipCode>100323702</ZipCode>
<StreetAddress><![CDATA[630 West 168th St]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>New York</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>13</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>NY13</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>7626</Code>
<Text>SciSIP-Sci of Sci Innov Policy</Text>
</ProgramElement>
<ProgramElement>
<Code>8800</Code>
<Text>SCIENCE RESOURCES STATISTICS</Text>
</ProgramElement>
<ProgramReference>
<Code>7626</Code>
<Text>SCIENCE OF SCIENCE POLICY</Text>
</ProgramReference>
<Appropriation>
<Code>0117</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2017~427892</FUND_OBLG>
<POR>
<DRECONTENT><![CDATA[<div class="porColContainerWBG"> <div class="porContentCol"><!-- p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px 'Helvetica Neue'; color: #454545} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px 'Helvetica Neue'; color: #454545; min-height: 14.0px} p.p3 {margin: 0.0px 0.0px 2.0px 0.0px; font: 14.0px 'Helvetica Neue'; color: #454545} span.s1 {text-decoration: underline ; color: #e4af0a} --> <p class="p1">About a quarter of the National Institutes of Health Budget (and a considerable share of federal R&amp;D funding) are spent on indirect costs. Indirect costs may include items such as general and research administration, facilities, heating, lighting, and library services, paid to institutions above and beyond direct costs of a specific research project. Since the mid-1960s, institutional indirect cost rates have been determined through each institution&rsquo;s negotiations with the federal government, and there is considerable variation across institutions and over time.<span>&nbsp;</span></p> <p class="p2">&nbsp;</p> <p class="p1">Government indirect cost recovery (ICR) policy has been a controversial topic since the end of World War II. On one hand, agency heads, Congress, and faculty believe that high indirect cost rates mean less money for actual research. Faculty at individual institutions sometimes feel their chances to get grants are hurt by high ICR, making them less likely to be funded than peers. There is concern high ICR rates create incentives for institutions to go after more grants and to make other investments they would not otherwise. On the other hand, university administrators and associations representing them have argued that ICR rates undercompensate universities, and that it is impossible for a university to make money on ICR given audits and other procedures.</p> <p class="p2">&nbsp;</p> <p class="p1">Much of this controversy has centered on the National Institutes of Health (NIH). As a result, Congress and the General Accounting Office, among many others, have periodically called on the NIH to re-assess the impact of ICR policy on its mission. Nearly all previous reports over the postwar era have highlighted a lack of reliable data on indirect cost rates to assess these issues. Though current rate agreements often are publicly available, few institutions report historical rates, and there is no central source of data. This makes longitudinal analysis difficult. This has been an obstacle to academics studying the science of science policy, to journalists, funders, and policymakers trying to understand the system, and to individual research institutions seeking funding.</p> <p class="p2">&nbsp;</p> <p class="p3">This project has produced the first comprehensive dataset on indirect cost rates for NIH grantees and other institutions. The project team obtained raw rate information using data from several freedom of information act (FOIA) requests, including nearly 6000 negotiated indirect cost rate agreements. The data were cleaned, standardized and consolidated, linked to standard institutional identifiers. Both raw and processed data (along with a detailed data documentation guide for users) have been posted publicly (<a href="%22"><span class="s1">https://github.com/bhavensampat/indirectcostdata</span></a>).<span>&nbsp;</span></p> <p class="p2">&nbsp;</p> <p class="p1">In addition to this dataset the project team located new historical data on rates from the National Archives, which also will be posted to the site above once it is cleaned and validated.<span>&nbsp;</span></p> <p class="p2">&nbsp;</p> <p class="p1">Analyses using the new data have been disseminated to policymakers and scholars through conference presentations and seminars. The grant also helped support the training, mentoring, and professional development of a new S&amp;T policy scholar (who worked on the data collection, cleaning, and documentation) who recently started his PhD studies in public policy.<span>&nbsp;</span></p> <p class="p2">&nbsp;</p> <p>&nbsp;</p><br> <p>            Last Modified: 02/07/2020<br>      Modified by: Bhaven&nbsp;Sampat</p> </div> <div class="porSideCol"></div> </div>]]></DRECONTENT>
<POR_COPY_TXT><![CDATA[ About a quarter of the National Institutes of Health Budget (and a considerable share of federal R&amp;D funding) are spent on indirect costs. Indirect costs may include items such as general and research administration, facilities, heating, lighting, and library services, paid to institutions above and beyond direct costs of a specific research project. Since the mid-1960s, institutional indirect cost rates have been determined through each institutionâ€™s negotiations with the federal government, and there is considerable variation across institutions and over time.    Government indirect cost recovery (ICR) policy has been a controversial topic since the end of World War II. On one hand, agency heads, Congress, and faculty believe that high indirect cost rates mean less money for actual research. Faculty at individual institutions sometimes feel their chances to get grants are hurt by high ICR, making them less likely to be funded than peers. There is concern high ICR rates create incentives for institutions to go after more grants and to make other investments they would not otherwise. On the other hand, university administrators and associations representing them have argued that ICR rates undercompensate universities, and that it is impossible for a university to make money on ICR given audits and other procedures.   Much of this controversy has centered on the National Institutes of Health (NIH). As a result, Congress and the General Accounting Office, among many others, have periodically called on the NIH to re-assess the impact of ICR policy on its mission. Nearly all previous reports over the postwar era have highlighted a lack of reliable data on indirect cost rates to assess these issues. Though current rate agreements often are publicly available, few institutions report historical rates, and there is no central source of data. This makes longitudinal analysis difficult. This has been an obstacle to academics studying the science of science policy, to journalists, funders, and policymakers trying to understand the system, and to individual research institutions seeking funding.   This project has produced the first comprehensive dataset on indirect cost rates for NIH grantees and other institutions. The project team obtained raw rate information using data from several freedom of information act (FOIA) requests, including nearly 6000 negotiated indirect cost rate agreements. The data were cleaned, standardized and consolidated, linked to standard institutional identifiers. Both raw and processed data (along with a detailed data documentation guide for users) have been posted publicly (https://github.com/bhavensampat/indirectcostdata).    In addition to this dataset the project team located new historical data on rates from the National Archives, which also will be posted to the site above once it is cleaned and validated.    Analyses using the new data have been disseminated to policymakers and scholars through conference presentations and seminars. The grant also helped support the training, mentoring, and professional development of a new S&amp;T policy scholar (who worked on the data collection, cleaning, and documentation) who recently started his PhD studies in public policy.             Last Modified: 02/07/2020       Submitted by: Bhaven Sampat]]></POR_COPY_TXT>
</POR>
</Award>
</rootTag>
